Concentrix
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 month.
- Recent price momentum is +3.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 13.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation A+
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 4.8x | Better than 98% |
| Price / Sales | 0.2x | Better than 98% |
Growth B-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 15.8% | Better than 77% |
| Net income CAGR (3Y) | -14.8% | Better than 22% |
| Free cash flow CAGR (3Y) | 7.5% | Better than 49% |
Profitability D+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 35.0% | Better than 40% |
| Operating margin | 6.2% | Better than 39% |
| Net margin | -13.1% | Better than 15% |
| Return on equity | -37.8% | Better than 11% |
| Return on invested capital | -13.2% | Better than 16% |
Momentum B
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 15.2% | Better than 94% |
| 6-month return | 12.9% | Better than 76% |
| 12-month return (ex latest month) | -3.7% | Better than 30% |
| Distance below 52-week high | 31.3% | Better than 41% |
Financial Health C-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.4x | Better than 37% |
| Debt to assets | 43.1% | Better than 23% |
| Interest coverage | -3.1x | Better than 19% |
| Free cash flow / net income | 170.7% | Better than 71% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 66.7% | Better than 41% |
| Upside to average target | 18.5% | Better than 30% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 28.56
- Open
- 28.50
- Day range
- 28.35 - 30.13
- Avg price
- 29.39
- Volume
- 693.81K
- Turnover
- 20.39M
- Turnover ratei
- 1.24%
- Volume ratioi
- 1.07
- Amplitudei
- 6.25%
- 52-week rangei
- 18.60 - 42.58
Valuation
- P/Ei
- -1.44
- P/E (TTM)i
- -0.76
- P/Bi
- 1.01
- EPSi
- -20.36
- Book value / shi
- 28.95
- Net profit
- -1.24B
- Net assets
- 1.77B
Share structure
- Market cap
- 1.79B
- Float capi
- 1.64B
- Shares out
- 61.11M
- Float sharesi
- 56.04M
Dividend & listing
- Div yield (TTM)i
- 4.92%
- Dividend (TTM)
- 1.44
- Listing date
- 2015-07-01
31.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-8.97M net over the window
Short interest
- Shares short
- 8.01M
- % of floati
- 13.11%
- Days to coveri
- 8.19
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Concentrix (CNXC)?
Concentrix last traded at 29.26. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Concentrix's market cap?
About 1.79B.
What is the P/E ratio of Concentrix?
The trailing twelve-month P/E is -0.76, below its own 5-year average of 2.63 — toward the bottom of its historical range (17.07% percentile). See the Valuation tab for the full history.
Does Concentrix pay a dividend?
Yes. The trailing dividend yield is 4.92%. The 2025 payout was up 9.5% from 2024. See the Dividends tab for the full payment history.
Is Concentrix a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 34.67, which implies 18.5% upside from the current price. This is not investment advice.
What is Concentrix's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Concentrix a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Concentrix discussion 0 comments